IL13 and cancer: IL-13Rα2, one of the IL-13 receptors, is highly expressed in some cancer cells, including GBM23 and OSCC24; therefore, targeting this receptor, such as CAR-T and IL13-PE, would be new strategy for these cancer patients25.